Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (10740)	4/27/2016 2:12:14 PM
From: tuck	Read Replies (1) \| Respond to of 12215

>>Top dose drop? Mkt must figure odds of success drop. Seems overdone. << Reread the PR and the protocol, and yup, that's the deal. I guess it took a few minutes for everyone else to dig out the doses that were being tested. Thus the spike and drop. The protocol is "active, not recruiting" and shows the doses as 1, 2, and 5 mg/kg. I figured that would be the outcome of the hold, but failed to put it together myself in advance. A shame. Had I dug this out earlier on my own, I would sold that spike and been better off. Fail on my part. I've been distracted lately, and my research may be superficial. I'm not sure they even have data for doses as low as are now to be tested: CR845, A Novel Peripherally-Acting Kappa Opioid Receptor Agonist, Provides Post-Operative Analgesia as Well as Reduces Post-Operative Nausea and Vomiting So, BJ, what gives you the confidence to buy here? I have an order in for a small tranche at $6. I did manage to bail a couple of positions a couple of days ago, to raise cash, and feel better about it. Cheers, Tuck